US4866061066

Overall **KYN** gets a fundamental rating of **2** out of 10. We evaluated **KYN** against 0 industry peers in the **Unkown** industry. Both the profitability and financial health of **KYN** have multiple concerns. **KYN** has a expensive valuation and it also scores bad on growth.

The reported net income has been mixed in the past 5 years: **KYN** reported negative net income in multiple years.

In the past 5 years **KYN** always reported a positive cash flow from operatings.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.92% | ||

ROE | 4.06% | ||

ROIC | 0.41% |

ROA(3y)-8.59%

ROA(5y)-4.69%

ROE(3y)-12.59%

ROE(5y)-6.79%

ROIC(3y)N/A

ROIC(5y)N/A

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 16.04% | ||

PM (TTM) | 95.93% | ||

GM | 27.26% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

Compared to 1 year ago, **KYN** has more shares outstanding

The number of shares outstanding for **KYN** has been increased compared to 5 years ago.

The Debt to FCF ratio of **KYN** is **2.31**, which is a good value as it means it would take **KYN**, **2.31** years of fcf income to pay off all of its debts.

Even though the debt/equity ratio score it not favorable for **KYN**, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.3 | ||

Debt/FCF | 2.31 | ||

Altman-Z | 1.06 |

ROIC/WACCN/A

WACCN/A

A Quick Ratio of **0.23** indicates that **KYN** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.23 | ||

Quick Ratio | 0.23 |

The earnings per share for **KYN** have decreased strongly by **-83.27%** in the last year.

Measured over the past years, **KYN** shows a very strong growth in **Revenue**. The Revenue has been growing by **22.28%** on average per year.

EPS 1Y (TTM)-83.27%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q633.33%

Revenue 1Y (TTM)15.1%

Revenue growth 3Y5.31%

Revenue growth 5Y22.28%

Revenue growth Q2Q-13.84%

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

Compared to an average S&P500 **Price/Earnings** ratio of **26.35**, **KYN** is valued at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 22.15 | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 6.85 | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

With a **Yearly Dividend Yield** of **9.54%**, **KYN** is a good candidate for dividend investing.

Compared to an average S&P500 **Dividend Yield** of **2.46**, **KYN** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 9.54% |

The dividend of **KYN** decreases each year by **-14.30%**.

The dividend of **KYN** decreased in the last 3 years.

Dividend Growth(5Y)-14.3%

Div Incr Years2

Div Non Decr Years2

DP197.45%

EPS Next 2YN/A

EPS Next 3YN/A

**KAYNE ANDERSON ENERGY INFRAS**

NYSE:KYN (2/23/2024, 7:04:00 PM)

**9.08**

**-0.09 (-0.98%) **

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.24B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 9.54% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 22.15 | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.92% | ||

ROE | 4.06% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 16.04% | ||

PM (TTM) | 95.93% | ||

GM | 27.26% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.03

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.3 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.23 | ||

Quick Ratio | 0.23 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-83.27%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)15.1%

Revenue growth 3Y5.31%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y